Sarepta therapeutics stock news

See also: Sarepta therapeutics stock dropSarepta therapeutics stock newsSarepta therapeutics stock chartSarepta therapeutics stock quoteSarepta therapeutics stock splitSarepta therapeutics stock price

Keywords Suggestions

Sarepta therapeutics stock news

( Please select at least 2 keywords )

Related websites

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Why Sarepta Therapeutics Tumbled Today
  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ: SRPT) stock fell by over 12% today.

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 35

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 42

What’s Next For Sarepta Stock After A 12% Fall

Sarepta Therapeutics stock rose 3.7% the last twenty-one trading days (one month), compared to broader market (S&P500) decline of 2.0%; A change of 3.7% or more over twenty-one trading days is a

Forbes.com   DA: 14 PA: 50 MOZ Rank: 67

Sarepta Therapeutics (SRPT) Stock Price, News & Info The

Real time Sarepta Therapeutics (SRPT) stock price quote, stock graph, news & analysis.

Fool.com   DA: 12 PA: 19 MOZ Rank: 35

Why Sarepta Therapeutics Fell 14.7% This Week The Motley

  • The stock dropped more than $13 a share over the course of the week
  • Sarepta specializes in gene therapies to treat rare neurological disorders
  • Sarepta Therapeutics (NASDAQ:SRPT), a biotech

Fool.com   DA: 12 PA: 50 MOZ Rank: 67

SRPT -- Is Its Stock Price A Worthy Investment

  • Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 12.96% of US stocks have a lower such ratio
  • SRPT's price/sales ratio is 12.66; that's higher than the P/S ratio of 86.12% of US stocks.

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 31

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, Quote

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 35

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ:SRPT) stock fell by over 12% today
  • Investors were displeased with a company update about its

Fool.com   DA: 12 PA: 50 MOZ Rank: 70

Sarepta Therapeutics Inc. (SRPT) stock is a mispriced

  • The stock was resumed by Credit Suisse, who disclosed in a research note on April 26, 2021, to Neutral and set the price objective to $72
  • In their research brief published January 12, 2021, Citigroup analysts downgraded the Sarepta Therapeutics Inc

Bovnews.com   DA: 11 PA: 50 MOZ Rank: 70

After A 50% Fall Sarepta Therapeutics Stock Now Looks

  • Sarepta Therapeutics stock, is a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases

Forbes.com   DA: 14 PA: 50 MOZ Rank: 74

News & Press Releases Sarepta Therapeutics

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/2021 Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock

Sarepta.com   DA: 15 PA: 9 MOZ Rank: 35

Do Analysts Agree Monday on Sarepta Therapeutics Inc (SRPT

  • What's Happening With Sarepta Therapeutics Inc Stock Today? Sarepta Therapeutics Inc (SRPT) stock is down -4.94% while the S&P 500 has risen 0.47% as of 10:42 AM on Monday, Oct 11
  • SRPT is down -$4.91 from the previous closing price of $99.42 on volume of 788,801 shares
  • Over the past year the S&P 500 has gained 24.83% while SRPT is down -33.85%.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 87

SRPT Stock Forecast, Price & News (Sarepta Therapeutics)

  • 20 analysts have issued 1 year target prices for Sarepta Therapeutics' stock
  • Their forecasts range from $85.00 to $215.00
  • On average, they expect Sarepta Therapeutics' stock price to reach $131.56 in the next year
  • This suggests a possible upside of 58.1% from the stock's current price.

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 51

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • News Sarepta Therapeutics Inc.SRPT
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings

Wsj.com   DA: 11 PA: 24 MOZ Rank: 49

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 43

SAREPTA THERAPEUTICS, INC. : Stock Market News and

  • SAREPTA THERAPEUTICS : Credit Suisse Raises Sarepta Therapeutics' PT to $75 from $72, Keep.
  • All news about SAREPTA THERAPEUTICS, INC
  • PRESS RELEASE : Roche presents new data at World Muscle Society (WMS) 2021 highlighting ne.
  • (NASDAQGS : SRPT) dropped from FTSE All-World Index.

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 88

SRPT News Today (Sarepta Therapeutics) MarketBeat

  • Sarepta Therapeutics to Initiate Part B of MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Following Positive Interactions with FDA
  • finance.yahoo.com - September 27 at 12:59 PM
  • (NASDAQ:SRPT) Given Average Recommendation of "Buy" by Analysts.

Marketbeat.com   DA: 18 PA: 25 MOZ Rank: 60

Q3 2021 EPS Estimates for Sarepta Therapeutics, Inc

  • Sarepta Therapeutics has a 1 year low of $65.30 and a 1 year high of $181.83
  • The company has a debt-to-equity ratio of 2.25, a current ratio of 5.33 and a quick ratio of 4.70
  • The stock's fifty day moving average price is $83.83 and its 200-day moving average price is $77.52
  • Sarepta Therapeutics (NASDAQ:SRPT) last released its quarterly

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 86

Sarepta Therapeutics Inc. (NASDAQ: SRPT) Stock Seems Like

  • (NASDAQ:SRPT) shares, rose in value on Thursday, October 14, with the stock price up by 1.81% to the previous day’s close as strong demand from buyers drove the stock to $84.73
  • Actively observing the price movement in the recent trading, the stock …

Stocksregister.com   DA: 18 PA: 50 MOZ Rank: 87

SRPT Stock News SAREPTA THERAPEUTICS Stock Price Today

SRPT: Get the latest Sarepta Therapeutics stock price and detailed information including SRPT news, historical charts and realtime prices.

Markets.businessinsider.com   DA: 27 PA: 18 MOZ Rank: 65

Analysts Mean recommendation for Sarepta Therapeutics Inc

The Stock rose vividly during the last session to $97.95 after opening rate of $96.17 while the lowest price it went was recorded $90.51 before closing at $99.42.Recently in News on October 11, 2021, Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional Improvements in Multiple Studies of Patients with Duchenne.

Investchronicle.com   DA: 19 PA: 50 MOZ Rank: 90

Sarepta Therapeutics Announces Proposed $500,000,000

  • 12, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (Nasdaq:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and other conditions, $500,000,000 in shares of its common stock in an underwritten public offering.

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 28

SRPT: Sarepta Therapeutics Inc

Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 47

Sarepta Therapeutics Inc. [SRPT] is -51.32% lower this YTD

  • [NASDAQ: SRPT] closed the trading session at $83.00 on 10/14/21
  • The day’s price range saw the stock hit a low of $82.27, while the highest price level was $85.75
  • The company report on October 14, 2021 that Sarepta Therapeutics Announces Pricing of …

Dbtnews.com   DA: 11 PA: 50 MOZ Rank: 85

Expert Ratings For Sarepta Therapeutics Markets Insider

  • 2 days ago · In the last 3 months, 6 analysts have offered 12-month price targets for Sarepta Therapeutics
  • The company has an average price target of $95.33 with a high of $125.00 and a …

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 25

Sarepta Stock Sinks After Announcing a Stock Sale. It's

  • Sarepta Therapeutics stock is falling after the biotech company said it would sell more stock and provided an update on product revenue

Barrons.com   DA: 15 PA: 46 MOZ Rank: 87

SRPT Sarepta Therapeutics Inc. Stock Overview (U.S

  • Complete Sarepta Therapeutics Inc
  • View real-time SRPT stock price and news, along with industry-best analysis.

Barrons.com   DA: 15 PA: 24 MOZ Rank: 66

Why Sarepta Therapeutics Fell 14.7% This Week

  • Sarepta Therapeutics (NASDAQ: SRPT), a biotech company that specializes in genetic therapies for rare diseases, dropped 14.7% this week, according to data from S&P Global Market Intelligence

Msn.com   DA: 11 PA: 50 MOZ Rank: 89

Sarepta Therapeutics, Inc. (SRPT) Stock Price, Quote

  • Get a real-time Sarepta Therapeutics, Inc
  • (SRPT) stock price quote with breaking news, financials, statistics, charts and more.

Stockanalysis.com   DA: 17 PA: 13 MOZ Rank: 59

Expert Ratings For Sarepta Therapeutics

  • In the last 3 months, 6 analysts have offered 12-month price targets for Sarepta Therapeutics
  • The company has an average price target of $95.33 with a high of $125.00 and a …

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 96

Sarepta Therapeutics, Inc. (SRPT) Prices $500 Million

  • 13, the genetic medicine firm Sarepta Therapeutics, Inc
  • announced its pricing for an underwritten public offering of 6,172,840 shares of the company’s common stock
  • The price offered to the public will be $81.00 per share
  • Pre-market today, SRPT stock increased 0.36% in price, up to $83.52 per share.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 19

Premarket Mover: Sarepta Therapeutics Inc (SRPT) Up 2.11%

  • Sarepta Therapeutics Inc ( SRPT) is up 2.11% today
  • SRPT has an Overall Score of 44
  • Find out what this means to you and get the rest of the rankings on SRPT! SRPT stock closed at $84.19 and is up $1.78 during pre-market trading
  • Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 18

Sarepta Therapeutics News

  • Sarepta Therapeutics (SRPT) stock price, charts, trades & the US's most popular discussion forums
  • Free forex prices, toplists, indices and lots more

Advfn.com   DA: 13 PA: 30 MOZ Rank: 76

Sarepta Therapeutics Inc(SRPT) Stock Price,News,Quote-Moomoo

  • Sarepta Therapeutics Starts $500 Million Common Stock Offering
  • 04:08 PM EDT, 10/12/2021 (MT Newswires) -- Sarepta Therapeutics (SRPT) said Tuesday it started an underwritten public offering of $500 million in common shares

Moomoo.com   DA: 14 PA: 20 MOZ Rank: 68

Investor Relations Sarepta Therapeutics, Inc.

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/21 Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock

Investorrelations.sarepta.com   DA: 29 PA: 29 MOZ Rank: 93

Sarepta Therapeutics Stock Quote. SRPT

  • Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases
  • It targets a broad range of diseases while focusing on the rapid development of its drug candidates
  • Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 98

The Zacks Analyst Blog Highlights: CRISPR Therapeutics

  • 2 days ago · The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 13

Sarepta Therapeutics: SRPT Stock Price Quote & News

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases
  • The company was founded on July 22, 1980 and is headquartered in Cambridge, MA

Robinhood.com   DA: 13 PA: 12 MOZ Rank: 63

Sarepta Therapeutics Inc SRPT

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases

Money.usnews.com   DA: 16 PA: 47 MOZ Rank: 11

Sarepta Therapeutics News

  • Sarepta Therapeutics to Showcase Data from its Gene Therapy.
  • Sarepta Therapeutics to Present at Upcoming Investor.
  • Sarepta Therapeutics Announces Recipients of Route 79, The.
  • Sarepta Therapeutics Announces Inducement Grants Under.

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 10

Sarepta Therapeutics (NASDAQ:SRPT) Stock Price, News

Sarepta Therapeutics (NASDAQ: SRPT) stock price, news, charts, stock research, profile.

Benzinga.com   DA: 16 PA: 11 MOZ Rank: 68

SRPT Stock Pops After Gene Therapy Beats Sarepta's Own

  • SRPT Stock Rises On Gene Therapy Test
  • Sarepta's gene therapy aims to replace the gene that codes for the beta-sarcoglycan protein
  • Sarepta said in a news release

Investors.com   DA: 17 PA: 50 MOZ Rank: 8

Sarepta Therapeutics Announces Pricing of $500 Million

  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of 6,172,840 shares of its common stock at a price to the public of $81.00 per share.

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 7

SAREPTA THERAPEUTICS, INC. : SRPT Stock Price

  • The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases
  • It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD).

Marketscreener.com   DA: 22 PA: 47 MOZ Rank: 6

Sarepta Therapeutics Announces Pricing of $500 Million

  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of 6,172,840 shares of its common stock …

Stockhouse.com   DA: 14 PA: 50 MOZ Rank: 5

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Benimsayfam.com 125 days leftReg2C.com Inc.Amazon Technologies Inc.
Oliverpyattcenters.com 326 days leftGoDaddy.com, LLCCloudflare, Inc.
Liveat7900.com2 years, 340 days leftGoDaddy.com, LLCGoDaddy.com, LLC
Galtro.com 119 days leftGoDaddy.com, LLCLiquid Web, L.L.C
Pokemongopromocodes.net 177 days leftGoDaddy.com, LLCCloudflare, Inc.
Rhbinvest.com1 year, 53 days leftWeb Commerce Communications Limited dba WebNic.ccAmazon Technologies Inc.
Empower-retirement.com 359 days leftCSC Corporate Domains, Inc.Great-West Life Assurance Company
Albendazoletablets.com 48 days leftHosting Concepts B.V. d/b/a OpenproviderCloudflare, Inc.
Trane.com 283 days leftNetwork Solutions, LLCAmazon Technologies Inc.
Meporch.com 92 days leftGoDaddy.com, LLCGoogle LLC

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]